Calibre Scientific Acquires NeXtal Biotechnologies from Qiagen

January 8, 2020

Calibre Scientific has acquired the NeXtal Biotechnologies line of structural biology products (including EasyXtal crystallization plates) from Qiagen NV. The purchase expands Calibre's structural biology and protein crystallization product portfolio, supplying academic, biotechnology, and pharmaceutical customers.

Targets
NeXtal Biotechnologies
Sellers
Qiagen NV
Industry
Biotechnology
Location
Ohio, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.